Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Vanda Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Vanda Pharmaceuticals (United States)

Washingtoncompany

209

Works

13,465

Citations

63

h-index

Top Research Topics

Circadian rhythm and melatonin Sleep and Wakefulness Research Sleep and related disorders

Top Researchers

Maurizio Fava Massachusetts General Hospital

1,222 works88,329 citationsh-index: 137

Recent Research

A potential association of SLC2A9 variant rs7442295 with uric acid at baseline and in interaction with iloperidone

Sandra Smieszek,Sean R. Chadwick,et al.

20260 citations

Gastrointestinal motility and disorders

SARS-CoV-2 and COVID-19 Research

Dermatology and Skin Diseases

COVID-19 Clinical Research Studies

Genetics and Neurodevelopmental Disorders

Schizophrenia research and treatment

Epilepsy research and treatment

Acute Myeloid Leukemia Research

COVID-19 epidemiological studies

Michael Camilleri Commonwealth Scientific and Industrial Research Organisation

1,706 works83,441 citationsh-index: 146

Thomas Roth Henry Ford Health System

822 works54,093 citationsh-index: 110

Ron Do Icahn School of Medicine at Mount Sinai

282 works51,306 citationsh-index: 65

Thomas N. Chase Beth Israel Deaconess Medical Center

482 works35,486 citationsh-index: 96

Timothy M. E. Davis Emory Healthcare

876 works35,462 citationsh-index: 85

Selective ASO-based JAK2 inhibitor for the treatment of hematological malignancies with JAK2 V617F mutation burden

Bart Przychodzen,Sandra Smieszek

20250 citations

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial

Naoise C. Synnott,Christos Polymeropoulos,et al.

20251 citations

LB1184 Imsidolimab, a novel IgG4 IL36 receptor antagonist, was effective and well tolerated in patients with GPP

Sandra Smieszek

20251 citations

Selective ASO-based JAK2 inhibitor for the treatment of hematological malignancies with JAK2 V617F mutation burden.

Sandra Smieszek,Bartlomiej Przychodzen

20250 citations

Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial

Yunsheng He,Christos Polymeropoulos,et al.

20252 citations